Matches in DBpedia 2016-04 for { ?s ?p "Sirukumab (INN, USAN) (developmental code name CNTO-136) is a human monoclonal antibody designed for the treatment of rheumatoid arthritis. It acts against the proinflammatory cytokine Interleukin 6 (IL-6).Sirukumab is currently under development by Johnson & Johnson's subsidiary Centocor and has started clinical trials."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Sirukumab comment "Sirukumab (INN, USAN) (developmental code name CNTO-136) is a human monoclonal antibody designed for the treatment of rheumatoid arthritis. It acts against the proinflammatory cytokine Interleukin 6 (IL-6).Sirukumab is currently under development by Johnson & Johnson's subsidiary Centocor and has started clinical trials.".
- Q7530673 comment "Sirukumab (INN, USAN) (developmental code name CNTO-136) is a human monoclonal antibody designed for the treatment of rheumatoid arthritis. It acts against the proinflammatory cytokine Interleukin 6 (IL-6).Sirukumab is currently under development by Johnson & Johnson's subsidiary Centocor and has started clinical trials.".